Development of dissolution tests for oral extended-release products-Reference-Cited by-同舟云学术

Development of dissolution tests for oral extended-release products

Published:1998-06 Issue:3 Volume:1 Page:128-135
ISSN:1461-5347
Container-title:Pharmaceutical Science & Technology Today
language:en
Short-container-title:Pharmaceutical Science & Technology Today

Author:

Jorgensen Ellen D,Bhagwat Dileep

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference68 articles.

1. Malinowski, H.J. and Henderson, J.D. (1995) in Pharmacokinetics, Regulatory-Industrial-Academic Perspectives,(2nd edn) (Welling, P.G. and Tse, F.L.S., eds), pp. 451–477, Marcel Dekker

2. RATE OF DISSOLUTION OF DIGOXIN TABLETS AS A PREDICTOR OF ABSORPTION

3. CORRELATION OF DIGOXIN-TABLET DISSOLUTION-RATE WITH BIOLOGICAL AVAILABILITY

4. Therapeutic Non-equivalence of Digoxin Tablets in United Kingdom: Correlation with Tablet Dissolution Rate

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinib;Journal of Controlled Release;2024-06

2. INFLUENCE OF DISSOLUTION CONDITIONS ON THE DISSOLUTION RATE AND RELEASE MECHANISM OF KETOPROFEN FROM EXTENDED RELEASE HYDROPHILIC MATRIX SYSTEMS;FARMACIA;2022-04-25

3. Applications of USP apparatus 3 in assessing the in vitro release of solid oral dosage forms;Brazilian Journal of Pharmaceutical Sciences;2015-06

4. In vitro release testing of matrices based on starch–methyl methacrylate copolymers: Effect of tablet crushing force, dissolution medium pH and stirring rate;International Journal of Pharmaceutics;2014-01

5. Development and validation of a dissolution test for primaquine/polyethylene oxide matrix tablets;Química Nova;2013